| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Regeneron Pharmaceuticals (NASDAQ:REGN) has outperformed the market over the past 20 years by 19.15% on an annualized basis producing an average annual return of 27.55%. Currently, Regeneron Pharmaceuticals has a market capitalization of $131.42 billion.
Buying $1000 In REGN: If an investor had bought $1000 of REGN stock 20 years ago, it would be worth $132,765.03 today based on a price of $1192.23 for REGN at the time of writing.
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: REGN
